Mechanistically, hepatic Rab2A inhibition protected mice from high-fat diet–induced obesity and was associated with markedly elevated circulating FGF21, the phenotype largely rescued by adenovirus-mediated knockdown of either CREBH or APOB. This evidence concerns the gene FGF21 and obesity disorder.